Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribozymes in gene therapy of HIV-1.

J L Macpherson1, J A Ely, L Q Sun

  • 1Johnson & Johnson Research Laboratories, GPO Box 3331, Sydney, NSW 2001 Australia.

Frontiers in Bioscience : a Journal and Virtual Library
|June 3, 1999
PubMed
Summary

Ribozyme gene therapy offers a novel approach to combat Human Immunodeficiency Virus type 1 (HIV-1) by targeting viral RNA. This method shows potential for both viral load reduction and immune system restoration in HIV-1 patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiometer calibration using machine learning.

Scientific reports·2025
Same author

[Fetoscopy for intrauterine diagnosis and treatment of amniotic band syndrome: a clinical analysis of 7 cases and literature review].

Zhonghua fu chan ke za zhi·2024
Same author

[Association of urinary sodium excretion with fluid overload in patients with chronic kidney disease].

Zhonghua yi xue za zhi·2021
Same author

Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV-1 infection: A quantitative and qualitative study.

HIV medicine·2020
Same author

Clinical potential of gene therapy: towards meeting the demand.

Internal medicine journal·2014
Same author

Activation of toll-like receptor signaling pathway for protection against influenza virus infection.

Vaccine·2009

Area of Science:

  • Molecular biology
  • Virology
  • Gene therapy

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) causes Acquired Immune Deficiency Syndrome (AIDS).
  • HIV-1 is a complex RNA virus that integrates into host cell genomes.
  • Ribozymes are catalytic RNA molecules capable of targeting specific RNA sequences.

Purpose of the Study:

  • To explore ribozyme gene therapy as a potential treatment for HIV-1 infection.
  • To investigate the ability of ribozymes to suppress HIV-1 replication.
  • To assess the advantages of ribozyme gene therapy over conventional treatments.

Main Methods:

  • Designing ribozymes to target specific RNA sequences within the HIV-1 genome.
  • Demonstrating ribozyme efficacy in suppressing HIV-1 replication in cultured cells.

Related Experiment Videos

  • Evaluating ribozyme gene therapy for its impact on viral load and immune restoration.

    • Main Results:

    • Ribozymes can be designed to target genomic RNA and splice variants of HIV-1.
    • Studies have shown ribozymes can suppress HIV-1 replication in various cell cultures.
    • Ribozyme gene therapy presents potential for viral suppression and immune restoration.

    Conclusions:

    • Ribozyme gene therapy is a promising therapeutic strategy for HIV-1 infection.
    • This approach may offer advantages in managing viral load and restoring immune function.
    • Clinical trials are underway to test anti-HIV-1 ribozymes in patients.